LBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
LB PHARMACEUTICALS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$38.81+2.07 (+5.63%)
Close on Oct 19, 2026
- Market cap
- $1.17B
- P/E (TTM)
- –
- Dividend yield
- –
Lb Pharmaceuticals statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Lb Pharmaceuticals | Industry median |
|---|---|---|
| Market Cap | $1.25B | $166.30M |
| Enterprise Value | $927.08M | $88.19M |
| PB Ratio | 3.77 | 2.03 |
| P/TBV Ratio | 3.77 | 2.29 |
Income (trailing twelve months)
| Measure | Lb Pharmaceuticals | Industry median |
|---|---|---|
| Pretax Income | -$85.68M | -$14.34M |
| Net Income | -$85.69M | -$22.46M |
Returns
| Measure | Lb Pharmaceuticals | Industry median |
|---|---|---|
| Return on Equity (ROE) | -75.0% | -53.2% |
| Return on Assets (ROA) | -23.7% | -40.9% |
Balance sheet
| Measure | Lb Pharmaceuticals | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $324.90M | $61.43M |
| Net Cash (Debt) | $324.90M | $15.35M |
| Net Cash Per Share | $10.07 | $0.66 |
| Equity (Book Value) | $332.35M | $49.09M |
| Book Value Per Share | $10.30 | $1.37 |
| Tangible Book Value | $332.35M | $23.52M |
| Working Capital | $331.74M | $76.81M |
Financial position
| Measure | Lb Pharmaceuticals | Industry median |
|---|---|---|
| Current Ratio | 15.08 | 3.34 |
| Quick Ratio | 13.79 | 2.44 |
Cash flow (trailing twelve months)
| Measure | Lb Pharmaceuticals | Industry median |
|---|---|---|
| Operating Cash Flow | -$82.40M | -$12.35M |
| Capital Expenditures | -$435.00K | -$1.08M |
| Free Cash Flow | -$82.83M | -$20.22M |
| FCF Per Share | -$2.57 | -$0.42 |
Efficiency
| Measure | Lb Pharmaceuticals | Industry median |
|---|---|---|
| Profits Per Employee | -$3.17M | -$703.34K |
| Employee Count | 27 | 74 |
Dividends and yields
| Measure | Lb Pharmaceuticals | Industry median |
|---|---|---|
| Earnings Yield | -6.84% | -23.3% |
| FCF Yield | -6.62% | -8.72% |
Shares
| Measure | Lb Pharmaceuticals | Industry median |
|---|---|---|
| Shares Outstanding | 32,259,200 | 58,127,000 |
| Shares Change (QoQ) | 0.02% | 0.54% |
| Float | 26,865,400 | 49,136,700 |
| Shares Held by Insiders | 16.7% | 11.6% |
| Shares Held by Institutions | 95.5% | 59.4% |
Taxes
| Measure | Lb Pharmaceuticals | Industry median |
|---|---|---|
| Income Tax | $1.00K | $79.87K |
Scores
| Measure | Lb Pharmaceuticals | Industry median |
|---|---|---|
| Altman Z-Score | 25.92 | -0.22 |
| Piotroski F-Score | 4 | 4 |
Calculated by StockData from Lb Pharmaceuticals's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.